JB Pharma reports revenue growth of 9 per cent to Rs 882 crores in Q2 FY24
PAT increased by 36 per cent to Rs 151 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
USV, Biogenomics launch INSUQUICK, biosimilar Insulin Aspart for diabetes treatment
Insuquick will be available in cartridges, vials, and prefilled disposable pens
Myasthenia gravis market to generate sales of $6.7 bn across 7MM by 2032: GlobalData
GlobalData identified the influx of several new disease-modifying therapies (DMTs) within the past two years as the main driver of…
Biocon Biologics signs pact with Eris Lifesciences for divesture of dermatology and nephrology…
Total transaction value of the divestment is Rs 3,660 million, inclusive of working capital conveyed as part of the deal
Lupin launches Rocuronium Bromide Injection in US
It is indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to…
Accent Microcell files DRHP with NSE Emerge
The company will use net proceeds from the issue to invest in setting up a new plant at Navagam Kheda in Gujarat; it operates two…
GLP1R-targeting drugs dominate type 2 diabetes pipeline: GlobalData
This indicates a shift from the conventional IR to the GLP1R as the primary target for pioneering T2D treatments
Glenmark gets USFDA nod for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, 10 mg
The tablets will be distributed in the US by Glenmark Pharmaceuticals US
‘Trojan Horse’ chemical tool allows researchers to target ‘undruggable’ proteins
University of Dundee researchers have unlocked a class of proteins known as suppressor of cytokine signalling (SOCS)
Zydus gets USFDA nod for ZITUVIMET to treat adults with type 2 diabetes
ZITUVIMET contains active ingredients sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride, a…